Breast Cancer Management During the COVID-19 Pandemic: The Senologic International Society Survey
Tarih
2021Yazar
Mbodj, Mamadou
Mundinger, Alexander
Orda, Ruben
Ostapenko, Valerijus
Ozbas, Serdar
Ozmen, Vahit
Pagani, Olivia
Pienkowski, Tadeusz
Schneebaum, Schlomo
Shmalts, Ekaterina
Selim, Ashraf
Pavel, Zotov
Lodi, Massimo
Maghales-Costa, Mauricio
Mathelin, Carole
Ame, Shanti
Anyanwu, Stanley
Avisar, Eli
Boubnider, Wahib Mohcen
Breitling, Katrin
Anie, Hannah Ayettey
Conceicao, Jose Carlos
Dupont, Veronique
Elder, Elisabeth
Elfgen, Constanze
Elonge, Tony
Iglesias, Edelmiro
Imoto, Shigeru
Ioannidou-Mouzaka, Lydia
Kappos, Elisabeth A.
Kaufmann, Martin
Knauer, Michael
Luzuy, Franck
Margaritoni, Marko
Üst veri
Tüm öğe kaydını gösterÖzet
Objective: In early 2020, the spread of coronavirus disease-2019 (COVID-19) led the World Health Organization to declare this disease a pandemic. Initial epidemiological data showed that patients with cancer were at high risk of developing severe forms of COVID-19. National scientific societies published recommendations modifying the patients' breast cancer (BC) management to preserve, in theory, quality oncologic care, avoiding the increased risk of contamination. The Senology International Society (SIS) decided to take an inventory of the actions taken worldwide. This study investigates COVID-19-related changes concerning BC management and analyzes the will to maintain them after the pandemic, evaluating their oncological safety consequences.
Bağlantı
http://hdl.handle.net/20.500.12627/173710https://avesis.istanbul.edu.tr/api/publication/b707b638-bdde-4a63-8003-dce5fd55b9d6/file
https://doi.org/10.4274/ejbh.galenos.2021.2021-1-4
Koleksiyonlar
- Makale [2276]